A major UK clinical trial has shown that adding the corticosteroid dexamethasone to standard antiviral treatment for ...

Herpes simplex virus (HSV) encephalitis, caused by HSV types 1 and 2, is the most common sporadic viral encephalitis worldwide, with an annual incidence of around 2·2–4·6 per million people.1 Before ...

Alfasigma S.p.A. ("Alfasigma"), a global pharmaceutical company, and Innovative Molecules GmbH ("Innovative Molecules"), a clinical-stage biotechnology company, today announced a strategic partnership ...

A major UK clinical trial has shown that adding the corticosteroid dexamethasone to standard antiviral treatment for encephalitis (brain inflammation), caused by herpes simplex virus (HSV) does not ...

Please provide your email address to receive an email when new articles are posted on . Herpes simplex encephalitis (HSE) is likely the most serious herpes infection patients can face. Treatment ...

This case illustrates many of the diagnostic challenges that may be encountered in patients presenting with herpes simplex infection of the brain. The patient had presented with transient focal ...

The herpes simplex virus-1 can sometimes cause a dangerous brain infection. Combining an anti-inflammatory and an antiviral could help in these cases, report scientists with the Rajewsky and ...

Italian pharma Alfasigma has penned a 125 million euro ($145 million) deal for the rights to an injectable form of an investigational herpes simplex virus (HSV) encephalitis treatment. Germany’s ...

HSV-2 causes genital herpes, and neurological complications include aseptic meningitis and recurrent radiculopathy. HSV-2 also causes myelitis in immunocompromised individuals. Typical features of HSV ...

BOLOGNA, Italy and MUNICH, Jan. 14, 2026 /PRNewswire/ -- Alfasigma S.p.A. ("Alfasigma"), a global pharmaceutical company, and Innovative Molecules GmbH ("Innovative Molecules"), a clinical-stage ...